- Home
- HHH vs SWTX Comparison
HHH vs SWTX Comparison
Compare HHH & SWTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HHH
- SWTX
- Stock Information
- Founded
- HHH 2010
- SWTX 2017
- Country
- HHH United States
- SWTX United States
- Employees
- HHH N/A
- SWTX N/A
- Industry
- HHH Real Estate Investment Trusts
- SWTX Biotechnology: Pharmaceutical Preparations
- Sector
- HHH Real Estate
- SWTX Health Care
- Exchange
- HHH Nasdaq
- SWTX Nasdaq
- Market Cap
- HHH 3.3B
- SWTX 3.0B
- IPO Year
- HHH N/A
- SWTX 2019
- Fundamental
- Price
- HHH $66.35
- SWTX $37.92
- Analyst Decision
- HHH Strong Buy
- SWTX Strong Buy
- Analyst Count
- HHH 2
- SWTX 5
- Target Price
- HHH $82.00
- SWTX $72.40
- AVG Volume (30 Days)
- HHH 304.8K
- SWTX 2.2M
- Earning Date
- HHH 05-07-2025
- SWTX 05-01-2025
- Dividend Yield
- HHH 5.29%
- SWTX N/A
- EPS Growth
- HHH N/A
- SWTX N/A
- EPS
- HHH 3.96
- SWTX N/A
- Revenue
- HHH $1,750,689,000.00
- SWTX $191,589,000.00
- Revenue This Year
- HHH N/A
- SWTX $85.98
- Revenue Next Year
- HHH $45.83
- SWTX $69.16
- P/E Ratio
- HHH $11.58
- SWTX N/A
- Revenue Growth
- HHH 92.65
- SWTX 3417.33
- 52 Week Low
- HHH $56.24
- SWTX $28.21
- 52 Week High
- HHH $87.77
- SWTX $62.00
- Technical
- Relative Strength Index (RSI)
- HHH 39.32
- SWTX 39.33
- Support Level
- HHH $64.95
- SWTX $36.08
- Resistance Level
- HHH $66.82
- SWTX $38.77
- Average True Range (ATR)
- HHH 3.10
- SWTX 3.21
- MACD
- HHH -0.28
- SWTX -0.17
- Stochastic Oscillator
- HHH 35.77
- SWTX 36.05
About HHH Howard Hughes Holdings Inc.
Howard Hughes Holdings Inc owns, manages, and develops commercial, residential, and mixed-use real estate throughout the USA. Its portfolio is strategically positioned to meet and accelerate development based on market demand, resulting in one of the strongest real estate platforms in the country. It operates through four business segments: Operating Assets, MPCs, Strategic Developments and Seaport.
About SWTX SpringWorks Therapeutics Inc.
SpringWorks Therapeutics Inc is a clinical stage biopharmaceutical company applying a precision medicine approach to acquiring, developing and commercializing life-changing medicines for underserved patient populations suffering from devastating rare diseases and cancer. The company has a differentiated portfolio of small molecule targeted oncology product candidates and is advancing two potentially registrational clinical trials in rare tumor types, as well as several other programs addressing highly prevalent, genetically defined cancers.